Match!
Shellie D. Ellis
University of Kansas
Physical therapyProstate cancerFamily medicineClinical trialMedicine
46Publications
12H-index
510Citations
What is this?
Publications 47
Newest
#1Heather V. Nelson-Brantley (KU: University of Kansas)H-Index: 2
#2Carol Buller (KU: University of Kansas)H-Index: 1
Last. Shellie D. Ellis (KU: University of Kansas)H-Index: 12
view all 6 authors...
PURPOSE: To analyze the literature on advance care planning (ACP) in primary care through the lens of implementation science, with a focus on implications for rural settings. DESIGN: Scoping review of the literature. METHODS: The Cumulative Index of Nursing and Allied Health Literature (CINAHL), Medline, PsycINFO, and the Psychology and Behavioral Sciences Collection databases were searched for studies related to ACP adoption and implementation in primary care. The Theoretical Domains Framework ...
1 CitationsSource
#1Shellie D. Ellis (KU: University of Kansas)H-Index: 12
#2Mugur V. Geana (KU: University of Kansas)H-Index: 8
Last. Brantley Thrasher (KU: University of Kansas)H-Index: 1
view all 10 authors...
Background Few community urologists offer cancer patients the opportunity to participate in cancer clinical trials, despite national guidelines that recommend it, depriving an estimated 260,000 urological cancer patients of guideline-concordant care each year. Existing strategies to increase urologists’ offer of clinical trials are designed for resource-rich environments and are not feasible for many community urologists. We sought to design an implementation intervention for dissemination in un...
Source
#1Shellie D. Ellis (KU: University of Kansas)H-Index: 12
#2Mugur V. Geana (KU: University of Kansas)H-Index: 8
Last. Tomas L. Griebling (KU: University of Kansas)H-Index: 7
view all 9 authors...
Abstract Objective Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities. Methods We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trial...
1 CitationsSource
#1Shellie D. Ellis (KU: University of Kansas)H-Index: 12
#2Saleema A. Karim (University of Arkansas for Medical Sciences)H-Index: 3
Last. Jalal Uddin (UAB: University of Alabama at Birmingham)H-Index: 5
view all 5 authors...
Specialists, who represent 60% of physicians in the United States, are consolidating into large group practices, but the degree to which group practice type facilitates the delivery of high quality of care in specialty settings is unknown. We conducted a systematic literature review to identify the impact of group practice type on the quality of care among specialty providers. The search resulted in 913 articles, of which only 4 met inclusion criteria. Studies were of moderate methodological qua...
Source
#1Joanna Veazey Brooks (KU: University of Kansas)H-Index: 4
#2Shellie D. Ellis (KU: University of Kansas)H-Index: 12
Last. J. Brantley Thrasher (KU: University of Kansas)H-Index: 33
view all 5 authors...
For men diagnosed with prostate cancer, making treatment decisions can be overwhelming. Navigating treatment options, along with potential treatment side effects, can be difficult, and patients often rely heavily on the advice of their physicians. This study was aimed at understanding more about the way urologists talk with their patients about one treatment option: active surveillance (AS), a recognized management strategy for men with low-risk prostate cancer that includes close observation an...
2 CitationsSource
#1Christine B. Mackay (KU: University of Kansas)H-Index: 3
Last. Shellie D. Ellis (KU: University of Kansas)H-Index: 12
view all 5 authors...
BACKGROUND The Affordable Care Act (ACA) includes a mandate requiring most private health insurers to cover routine patient care costs for cancer clinical trial participation; however, the impact of this provision on cancer centers’ efforts to accrue patients to clinical trials has not been well described. METHODS First, members of cancer research centers and community-based institutions (n = 252) were surveyed to assess the status of insurance denials, and then, a focused survey (n = 77) collec...
4 CitationsSource
#1Justin Guinney (Sage Bionetworks)H-Index: 27
#2Tao Wang (UTSW: University of Texas Southwestern Medical Center)H-Index: 20
Last. Yuxin ZhuH-Index: 1
view all 174 authors...
Summary Background Improvements to prognostic models in metastatic castration-resistant prostate cancer have the potential to augment clinical trial design and guide treatment strategies. In partnership with Project Data Sphere, a not-for-profit initiative allowing data from cancer clinical trials to be shared broadly with researchers, we designed an open-data, crowdsourced, DREAM (Dialogue for Reverse Engineering Assessments and Methods) challenge to not only identify a better prognostic model ...
55 CitationsSource
#1Richard Meier (KU: University of Kansas)H-Index: 3
#2Stefan Graw (KU: University of Kansas)H-Index: 6
Last. Devin C. Koestler (KU: University of Kansas)H-Index: 31
view all 9 authors...
From March through August 2015, nearly 60 teams from around the world participated in the Prostate Cancer Dream Challenge (PCDC). Participating teams were faced with the task of developing prediction models for patient survival and treatment discontinuation using baseline clinical variables collected on metastatic castrate-resistant prostate cancer (mCRPC) patients in the comparator arm of four phase III clinical trials. In total, over 2,000 mCRPC patients treated with first-line docetaxel compr...
1 CitationsSource
#1Christine B. Mackay (KU: University of Kansas)H-Index: 3
#2Kaitlyn R. Antonelli (American Society of Clinical Oncology)H-Index: 2
Last. Shellie D. Ellis (KU: University of Kansas)H-Index: 12
view all 5 authors...
e14047Background: A recent federal initiative, the Cancer Moonshot, to develop and complete randomized clinical trials in four years for tens of thousands of US cancer patients may face a hurdle. A...
Source
#1Shellie D. Ellis (KU: University of Kansas)H-Index: 12
#2Emily Jones (KU: University of Kansas)H-Index: 4
Last. J. Brantley Thrasher (KU: University of Kansas)H-Index: 33
view all 5 authors...
e16618Background: Management of low-risk prostate cancer with active surveillance (AS) has increased, but AS is still underused. We sought to identify whether urologists' perceptions of barriers va...
1 CitationsSource
12345